Amazon launches a subscription prescription drug service, Health News, ET HealthWorld

New Delhi: Amazon is adding a prescription drug discount program to its growing health care business. The retail giant said Tuesday that it will launch RxPass, a subscription service for customers who have Prime memberships. Amazon said people will pay $5 a month to fill as many prescriptions as they need from a list of about 50 generic medications, which are generally cheaper versions of brand-name drugs. The company said the flat fee could cover a list of medications like the antibiotic amoxicillin and the anti-inflammatory drug naproxen. Sildenafil also…

Read More

Demand for Indian generic drugs skyrockets in China amid Covid surge, Health News, ET HealthWorld

New Delhi: The demand for Indian generic drugs has shot up in China amid the massive COVID surge in the country, with Chinese experts cautioning that fake versions of these drugs are flooding the market. China’s National Health Security Administration said on Sunday that Pfizer‘s Paxlovid oral medication, which is used to treat Covid-19, could not be included in the “register of drugs in the basic medical insurance”, because the company’s quotation was too high, media reports here said. Due to the massive short supply of Paxlovid, demand for Indian…

Read More

U.S. Supreme Court rebuffs Novartis, allows generic versions of MS drug – ET HealthWorld

Washington: The U.S. Supreme Court on Thursday turned down Novartis‘ bid to block the launch of generic versions of the company’s blockbuster multiple sclerosis drug Gilenya in a dispute with China’s HEC Pharm Co Ltd and other generic drugmakers. Novartis had asked the justices to suspend a lower court’s ruling that lifted a ban on generic versions of Gilenya, the Switzerland-based company’s third highest-selling drug last year with $2.8 billion in sales. Novartis sued HEC and more than a dozen other generic drugmakers, accusing them of patent infringement, in Delaware…

Read More

Sun Pharma plans in-licensing, buyouts to expand speciality business – ET HealthWorld

Sun Pharma, the country’s largest drugmaker, is looking for possible in-licensing opportunities and even acquisitions to bolster its global speciality business, a top executive said. “Organic efforts coupled with inorganic efforts will further fuel our pipeline, which could pave way for further traction of speciality revenues,” CS Muralidharan, group chief financial officer (CFO) of Sun Pharma, told ET in an interview. Speciality drugs refer to high cost, high complexity medicines, including biologicals, for the treatment of complex or rare conditions. They have limited competition or are protected by patents. But,…

Read More

Bucking the pandemic: India’s on its way to become the world’s pharmaceutical hub – ET HealthWorld

The Covid-19 pandemic might have pushed several economies and businesses to the brink, but what stood strong at such a crucial period was India’s pharmaceutical industry. The government’s focus on supporting the growth of the domestic pharma sector amid the pandemic couldn’t have been timed better, say sector stakeholders. Last month, the government had approved a production-linked incentive (PLI) scheme for the pharmaceutical sector, entailing an outlay of Rs 15,000 crore. Besides, the government has also approved a total of 33 applications with a committed investment of Rs 5,082.65 crore…

Read More